From lethal virus to life-saving vaccine: developing inactivated vaccines for pandemic influenza

Nature Reviews. Microbiology
John M Wood, James S Robertson

Abstract

Over the past eight years, cases of human infection with highly pathogenic avian influenza viruses have raised international concern that we could be on the brink of a global influenza pandemic. Many of these human infections have proved fatal and if the viruses had been able to transmit efficiently from person to person, the effects would have been devastating. How can we arm ourselves against this pandemic threat when these viruses are too dangerous to use in conventional vaccine production? Recent technological developments (reverse genetics) have allowed us to manipulate the influenza virus genome so that we can construct safe, high-yielding vaccine strains. However, the transition of reverse-genetic technologies from the research laboratory to the manufacturing environment has presented new challenges for vaccine manufacturers as well as veterinary and public health authorities.

References

Dec 1, 1977·The Journal of Infectious Diseases·P D ParkmanH M Meyer
May 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·M EnamiP Palese
Sep 2, 1998·British Journal of Urology·L C BerghmansE S van Waalwijk van Doorn
Dec 17, 1998·The New England Journal of Medicine·T LaskyR T Chen
Feb 17, 1999·Proceedings of the National Academy of Sciences of the United States of America·A H ReidJ K Taubenberger
Aug 4, 1999·Proceedings of the National Academy of Sciences of the United States of America·G NeumannY Kawaoka
Oct 9, 1999·Journal of Virology·E FodorA García-Sastre
May 10, 2000·Proceedings of the National Academy of Sciences of the United States of America·E HoffmannR G Webster
Aug 31, 2000·Virology·J K TaubenbergerT G Fanning
Sep 5, 2001·Virology·G Neumann, Y Kawaoka
Nov 16, 2001·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·J Yang, F P Tsai
Jan 17, 2002·The New England Journal of Medicine·UNKNOWN The American Lung Association Asthma Clinical Research Centers
Apr 5, 2002·Journal of Virology·Lois A ZitzowJacqueline M Katz
Aug 27, 2002·Nature Medicine·Sang Heui SeoRobert G Webster
Nov 30, 2002·Medical Microbiology and Immunology·N HehmeR Sänger
Jan 9, 2003·JAMA : the Journal of the American Medical Association·William W ThompsonKeiji Fukuda
Nov 12, 2003·Emerging Infectious Diseases·Ann H ReidJeffery K Taubenberger
Feb 28, 2004·Lancet·Maria Zambon
Feb 28, 2004·Lancet·J S M PeirisY Guan
Mar 20, 2004·Science·Edward C Holmes

❮ Previous
Next ❯

Citations

Jun 2, 2007·Medical Microbiology and Immunology·Jindrich CinatlHans W Doerr
Jun 23, 2009·Biotechnology Letters·Hongzhuan WuJoseph J Giambrone
Apr 7, 2005·Nature Medicine·Stanley A Plotkin
Mar 31, 2006·The New England Journal of Medicine·Gregory A Poland
Aug 12, 2009·Proceedings of the National Academy of Sciences of the United States of America·Haeman JangRichard J Smeyne
Feb 12, 2008·The Journal of Infectious Diseases·David I BernsteinHeather Hill
Sep 5, 2008·Journal of Virology·Shin MurakamiYoshihiro Kawaoka
Jun 29, 2007·Journal of Virology·Makoto OzawaYoshihiro Kawaoka
Feb 26, 2010·Journal of Virology·Lori W McGinnesTrudy G Morrison
May 5, 2011·World Journal of Biological Chemistry·Naoyoshi Maeda, Toshimitsu Uede
Feb 5, 2014·Trends in Biotechnology·Chengjun LiHualan Chen
Nov 15, 2006·Proceedings of the National Academy of Sciences of the United States of America·Jayanta HaldarAlexander M Klibanov
Nov 4, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gabriele NeumannYoshihiro Kawaoka
Jun 23, 2015·Expert Review of Vaccines·Barnaby E YoungYee Sin Leo
Jun 27, 2009·Expert Opinion on Biological Therapy·Geert Leroux-Roels
Jun 7, 2005·Expert Opinion on Biological Therapy·Mini ThomasJianzhu Chen
Oct 20, 2009·Vaccine·A H Ellebedy, R J Webby
Aug 31, 2007·Journal of Virological Methods·Chi Y WangHung J Liu
Apr 27, 2007·Advanced Drug Delivery Reviews·Mini ThomasAlexander M Klibanov
Mar 1, 2006·Pharmacotherapy·Stephen M Ford, John D Grabenstein
May 1, 2007·Influenza and Other Respiratory Viruses·Nigel J TempertonRobin A Weiss
Jan 1, 2008·Influenza and Other Respiratory Viruses·Vadim MettVidadi Yusibov
Jun 15, 2011·Influenza and Other Respiratory Viruses·Gabriel PedersenRebecca J Cox

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.